PharmaCorp Announces Grant of Stock Options

Barchart · 07/02 14:28

SASKATOON, Saskatchewan, July 02, 2025 (GLOBE NEWSWIRE) -- PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) has granted a total of 827,603 options to purchase common ‎shares to directors, officers, employees and consultants of the Corporation, with an exercise price of $0.48 and ‎an expiry date of July 1, 2035, subject to approval of the TSX Venture Exchange.

Read more at globenewswire.com

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.